<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical manifestations of hypopituitarism</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical manifestations of hypopituitarism</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical manifestations of hypopituitarism</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter J Snyder, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David S Cooper, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Martin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 06, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The presentation of hypopituitarism can be considered as the presentation of deficiency of each anterior pituitary hormone. The presentations of patients with deficiencies of those hormones that control target glands are often similar to the presentations of patients with primary deficiencies of the target gland hormones they control, with some notable exceptions.</p><p>An overview of the clinical manifestations in patients with hypopituitarism will be provided here. The causes, diagnosis, and treatment of hypopituitarism are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/6639.html" rel="external">"Diagnostic testing for hypopituitarism"</a> and  <a class="medical medical_review" href="/z/d/html/6640.html" rel="external">"Treatment of hypopituitarism"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">GENERAL PRINCIPLES</span><span class="headingEndMark"> — </span>Damage to the anterior pituitary can occur suddenly or slowly, can be mild or severe, and can affect the secretion of one, several, or all of its hormones. As a result, the clinical presentation of anterior pituitary hormone deficiencies varies, depending upon the following factors (see  <a class="medical medical_review" href="/z/d/html/6636.html" rel="external">"Causes of hypopituitarism"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>The rapidity with which a disease affects anterior pituitary cells. Some diseases, such as pituitary apoplexy, develop rapidly, causing sudden impairment of corticotropin (ACTH) secretion and, consequently, sudden onset of symptoms of cortisol deficiency. Other insults, such as radiation therapy to the pituitary or hypothalamus, usually act slowly, causing symptoms many months or, more likely, years later.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The severity of the hormonal deficiency. Complete ACTH and cortisol deficiency, as an example, can cause symptoms under basal circumstances, while partial ACTH deficiency may cause symptoms only during times of physical stress.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The number of different anterior pituitary cells that are affected, leading to impairment in the secretion of one, a few, or all the pituitary hormones (called panhypopituitarism). As a general rule, the secretion of gonadotropins and growth hormone is more likely to be affected than ACTH and thyroid-stimulating hormone (TSH). Many exceptions occur, however, so that one may see a patient who has only isolated ACTH deficiency. Thus, one cannot make an assumption about the status of one pituitary hormone from the status of another.</p><p></p><p>Patients in whom the hypopituitarism is due to a sellar mass may also have symptoms related to the mass, such as headache, visual loss, or diplopia. (See  <a class="medical medical_review" href="/z/d/html/6632.html" rel="external">"Causes, presentation, and evaluation of sellar masses"</a>.)</p><p class="headingAnchor" id="H5311650"><span class="h1">HORMONE DEFICIENCIES</span></p><p class="headingAnchor" id="H3"><span class="h2">ACTH</span><span class="headingEndMark"> — </span>The presentation of corticotropin (ACTH) deficiency (secondary adrenal insufficiency) is almost exclusively that of the resulting cortisol deficiency. In its most severe form, cortisol deficiency leads to death due to vascular collapse because cortisol is necessary for maintenance of peripheral vascular tone. A less severe form of the same phenomenon is postural hypotension and tachycardia. Mild, chronic deficiency may result in lassitude, fatigue, anorexia, weight loss, decreased libido, hypoglycemia, and eosinophilia. (See  <a class="medical medical_review" href="/z/d/html/159.html" rel="external">"Clinical manifestations of adrenal insufficiency in adults"</a>.)</p><p>There are two important clinical distinctions between cortisol deficiency due to ACTH deficiency and cortisol deficiency due to primary adrenal disease, which is also associated with aldosterone deficiency and secondary increases in pro-opiomelanocortin (POMC) and ACTH release (see  <a class="medical medical_review" href="/z/d/html/159.html" rel="external">"Clinical manifestations of adrenal insufficiency in adults"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Cortisol deficiency due to ACTH deficiency does not cause salt wasting, volume contraction, and hyperkalemia, because it does not result in clinically important deficiency of aldosterone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cortisol deficiency due to ACTH deficiency does not result in hyperpigmentation. In contrast, primary adrenal insufficiency, which is associated with secondary increases in POMC and ACTH, does result in hyperpigmentation.</p><p></p><p>Both forms of adrenal insufficiency can cause hyponatremia. This abnormality is due to inappropriate secretion of antidiuretic hormone (vasopressin) that is caused by cortisol (not aldosterone) deficiency [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/2314.html" rel="external">"Hyponatremia and hyperkalemia in adrenal insufficiency"</a>.)</p><p>It is important to realize that moderately severe ACTH and cortisol deficiency may cause few or no symptoms and no physical findings. Consequently, the adequacy of ACTH secretion should be evaluated biochemically in all patients who have pituitary or hypothalamic disease. (See  <a class="medical medical_review" href="/z/d/html/154.html" rel="external">"Determining the etiology of adrenal insufficiency in adults"</a> and  <a class="medical medical_review" href="/z/d/html/159.html" rel="external">"Clinical manifestations of adrenal insufficiency in adults", section on 'Secondary/tertiary adrenal insufficiency'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">TSH</span><span class="headingEndMark"> — </span>Common symptoms and signs of thyroid-stimulating hormone (TSH) deficiency include fatigue, cold intolerance, decreased appetite, constipation, facial puffiness, dry skin, bradycardia, delayed relaxation phase of the deep tendon reflexes, and anemia. The degree of symptoms and abnormal physical findings usually parallels the degree of thyroxine deficiency, but as the case with ACTH deficiency, some patients with marked TSH deficiency have few or no symptoms. (See  <a class="medical medical_review" href="/z/d/html/7846.html" rel="external">"Clinical manifestations of hypothyroidism"</a> and  <a class="medical medical_review" href="/z/d/html/7849.html" rel="external">"Central hypothyroidism", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H5"><span class="h2">Gonadotropins</span><span class="headingEndMark"> — </span>Deficient secretion of the gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH) results in hypogonadotropic hypogonadism (secondary hypogonadism) in both males and females.</p><p class="bulletIndent1"><span class="glyph">●</span>In women, hypogonadism means ovarian hypofunction, which results in anovulation and decreased estradiol secretion. The clinical consequences of estradiol deficiency in women with secondary hypogonadism are similar to those seen in women with primary hypogonadism (primary ovarian insufficiency [premature ovarian failure]). Findings in premenopausal women include irregular periods or amenorrhea, anovulatory infertility, hot flashes, and, eventually, vaginal atrophy. No physical findings of hypogonadism are detectable initially, but after several years, if estrogen therapy is not provided, breast tissue decreases and bone mineral density (BMD) declines. (See  <a class="medical medical_review" href="/z/d/html/7443.html" rel="external">"Clinical manifestations and diagnosis of primary ovarian insufficiency (premature ovarian failure)"</a>.)</p><p></p><p class="bulletIndent1">Serum androgen concentrations in women with hypopituitarism (particularly those with both gonadotropin and ACTH deficiency) are lower than those in normal control women [<a href="#rid2">2</a>] and appear to be correlated with BMD [<a href="#rid3">3</a>]. The clinical significance of this decrease has yet to be determined. (See  <a class="medical medical_review" href="/z/d/html/7447.html" rel="external">"Overview of androgen deficiency and therapy in females", section on 'Androgen deficiency'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In men, hypogonadism means testicular hypofunction, which results in decreased spermatogenesis and decreased testosterone secretion. The latter causes decreased energy and libido and hot flashes if sufficiently severe, within weeks to months, but does not cause decreased muscle mass (and perhaps strength) for several years. Testosterone deficiency also causes decreased BMD [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/7462.html" rel="external">"Clinical features and diagnosis of male hypogonadism"</a>.)</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Growth hormone</span><span class="headingEndMark"> — </span>Growth hormone deficiency in children typically presents as short stature (see  <a class="medical medical_review" href="/z/d/html/5832.html" rel="external">"Causes of short stature"</a>). Likely clinical manifestations of growth hormone deficiency in adults are changes in body composition (increased fat mass and decreased lean body mass) and decreased BMD in men. Also possible, but not yet confirmed, are decreased BMD in women, dyslipidemia, cardiovascular disease, impaired psychological function, and an increase in mortality. </p><p>Adults with growth hormone deficiency may also be more likely to have dyslipidemia and increased inflammatory markers and biochemical markers of endothelial function. The clinical manifestations of growth hormone deficiency in adults are reviewed in more detail separately. (See  <a class="medical medical_review" href="/z/d/html/6641.html" rel="external">"Growth hormone deficiency in adults", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Prolactin</span><span class="headingEndMark"> — </span>The only known clinical manifestation of prolactin deficiency is the inability to lactate after delivery. Isolated prolactin deficiency is rare; most patients with acquired prolactin deficiency have evidence of other pituitary hormone deficiencies [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H2546403009"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116762.html" rel="external">"Society guideline links: Pituitary tumors and hypopituitarism"</a>.)</p><p class="headingAnchor" id="H1311730"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/83818.html" rel="external">"Patient education: Panhypopituitarism (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H5311698"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General principles</strong> – The clinical presentation of anterior pituitary hormone deficiencies varies, depending upon the rapidity with which a disease affects anterior pituitary cells, the severity of the hormonal deficiency, and the number of hormone deficiencies. (See <a class="local">'General principles'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hormonal deficiencies</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>ACTH</strong> – The presentation of corticotropin (ACTH) deficiency is almost exclusively that of the resulting cortisol deficiency. There are two important clinical distinctions between cortisol deficiency due to ACTH deficiency (secondary adrenal deficiency) and cortisol deficiency due to adrenal disease (primary adrenal insufficiency) with a secondary increase in ACTH release (see <a class="local">'ACTH'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>ACTH deficiency does not cause salt wasting, volume contraction, and hyperkalemia, because it does not result in clinically important deficiency of aldosterone.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>ACTH deficiency does not result in hyperpigmentation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>TSH</strong> – The clinical manifestations of thyroid-stimulating hormone (TSH) deficiency (secondary/central hypothyroidism) are similar to those of primary hypothyroidism for similar degrees of deficiency. (See <a class="local">'TSH'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Gonadotropins</strong> – Deficient secretion of the gonadotropins follicle-stimulating hormone (FSH) and luteinizing hormone (LH) results in hypogonadotropic (secondary) hypogonadism in both females and males. (See <a class="local">'Gonadotropins'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Growth hormone</strong> – Growth hormone deficiency in children typically presents as short stature. Likely clinical manifestations of growth hormone deficiency in adults are changes in body composition (increased fat mass with a decrease in lean body mass) and decreased bone mineral density (BMD) in men. Also possible, but not yet confirmed, are decreased BMD in women, dyslipidemia, cardiovascular disease, impaired psychological function, and an increase in mortality. (See <a class="local">'Growth hormone'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Prolactin</strong> – The only known clinical manifestation of prolactin deficiency is the inability to lactate after delivery. (See <a class="local">'Prolactin'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 1989; 321:492.</a></li><li><a class="nounderline abstract_t">Miller KK, Sesmilo G, Schiller A, et al. Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 2001; 86:561.</a></li><li><a class="nounderline abstract_t">Miller KK, Biller BM, Hier J, et al. Androgens and bone density in women with hypopituitarism. J Clin Endocrinol Metab 2002; 87:2770.</a></li><li><a class="nounderline abstract_t">Stĕpán JJ, Lachman M, Zvĕrina J, et al. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989; 69:523.</a></li><li><a class="nounderline abstract_t">Mukherjee A, Murray RD, Columb B, et al. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis. Clin Endocrinol (Oxf) 2003; 59:743.</a></li></ol></div><div id="topicVersionRevision">Topic 6637 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2548097" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11158009" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Androgen deficiency in women with hypopituitarism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12050248" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Androgens and bone density in women with hypopituitarism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2788171" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14974916" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
